A study reveals that venetoclax consolidation after BTKi therapy is effective for chronic lymphocytic leukemia, offering ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

At a lymphoma conference, experts sparred about treatment options, while an outside expert highlighted the value of each approach.

The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

Two veteran biotech investors have reunited to form a new venture capital firm focusing on autoimmune diseases. Steven St. | ...

Vie Ventures, a new life sciences investment firm focused on bridging venture capital and disease philanthropy to develop breakthrough therapies for patients, today announced its official launch. Vie ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The program expired last year as a cost cutting measure. Though renewed, some still have qualms with the program.

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

The Radiation Exposure Compensation Act, which provides compensation for people harmed by exposure to nuclear testing and ...

A total of 1,288 confirmed cases have been reported in the US from the start of 2025 till July 8, making it the highest since ...

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts. On June 24, ...